Target / Biomarker
Discovery & Validation
Euretos is an AI (Artificial Intelligence) platform used by pre-clinical researchers for in-silico discovery & validation of targets and biomarkers. World leading pharma, biotech and academic institutions use it to accelerate their research. Available as subscription, consulting service or direct access
EURETOS AI PLATFORM
In Silico Multi Omics
Drive your in vitro and in vivo research by in silico multi omics analysis. Ask Euretos and evaluate how molecular mechanisms influence cell and tissue functions, and in turn mediate phenotypes and disease pathology.
FIND OUT MORE
Euretos invited to present on the use of AI in target & biomarker discovery at the annual Dutch Biotech EventWednesday 27 June 2018
On friday the 29th of June, Euretos will be speaking at the annual Dutch Biotech Event on the use of the Euretos AI Platform in target & biomarker discovery. In the session Arie Baak will speak on the topic together with Peter de Keizer, one of ...
Meet us at BioIT 2018! - Tuesday Morning May 15th at the FAIR Data HackathonMonday 14 May 2018
BioIT is starting today with the pre-conference workshops, including the one on FAIR data: http://www.bio-itworldexpo.com/fair-data-hackathon/. Over 200 people with an interest in using multi-omics data for life sciences research have already subsc ...
Prof David Webb (The Scripps Research Institute)
“The Euretos AI Platform is nothing less than an in silico way to save all drug and biotech researchers an infinite amount of blood, sweat and tears by providing
them with a powerful knowledge discovery platform.
The Euretos AI Platform allows the researcher to rapidly assess whether a given target, research area, etc., is related, even distantly, to another such entity thus allowing one to uncover hidden connections, leading to new knowledge.In the drug discovery arena, this thing is a gold mine.